Mei-Yin Polley to Clinical Trials as Topic
This is a "connection" page, showing publications Mei-Yin Polley has written about Clinical Trials as Topic.
Connection Strength
0.686
-
Development of omics-based clinical tests for prognosis and therapy selection: the challenge of achieving statistical robustness and clinical utility. Clin Trials. 2013 Oct; 10(5):653-65.
Score: 0.305
-
Leveraging external control data in the design and analysis of neuro-oncology trials: Pearls and perils. Neuro Oncol. 2024 May 03; 26(5):796-810.
Score: 0.160
-
Criteria for the use of omics-based predictors in clinical trials. Nature. 2013 Oct 17; 502(7471):317-20.
Score: 0.077
-
Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration. BMC Med. 2013 Oct 17; 11:220.
Score: 0.077
-
Conditional probability of survival in patients with newly diagnosed glioblastoma. J Clin Oncol. 2011 Nov 01; 29(31):4175-80.
Score: 0.067